Secondary immunoreaction in patients with neurosyphilis and its relevance to clinical outcomes
Open Access
- 6 June 2023
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 14, 1201452
Abstract
Background and purpose: Several reported cases of autoimmune conditions such as anti-NMDAR encephalitis and neuromyelitis optica (AQP4) have been considered to be potentially secondary to Treponema pallidum infection. Since the role of immune impairment in neurosyphilis is unclear, in this retrospective study, we examined the correlation of the immune impairment in patients with neurosyphilis with their clinical characteristics and outcomes.Methods: Clinical information was collected from patients with neurosyphilis in our center from January 2019 to December 2021. Cerebrospinal fluid (CSF) samples were subjected to indirect immunofluorescence tissue-based assay (IIF-TBA) on mouse brain sections and cell-based assay (CBA). The clinical characteristics and treatment outcomes of TBA-positive and-negative patients were compared.Results: A total number of 81 patients diagnosed with neurosyphilis were included. The results of the CBA tests showed that three cases had anti-NMDAR, AQP4, or GAD65 antibodies, respectively. By TBA test, 38 patients (38/81, 46.9%) had positive immunostains, including staining of neuronal cells in 21 cases (21/38, 55.3%), glial cells in 11 cases (11/38, 28.9%), and neuronal and glial cells in six cases (6/38, 15.8%). We then compared the clinical characteristics and treatment outcomes between the TBA-positive and-negative patients and found that TBA-positive staining was significantly correlated with syphilis antibody titers (p = 0.027 for serum and p = 0.006 for CSF) and head MRI abnormalities (p < 0.001 for parenchymal abnormalities and p = 0.013 for white matter lesions). The cognitive prognosis of TBA-positive neurosyphilis patients was significantly worse than that of TBA-negative patients (p < 0.001).Conclusion: The correlation between the TBA results and clinical data of our neurosyphilis patients imply the presence of secondary immune damage, which affected their prognosis. Therefore, TBA can be used as an additional biomarker for neurosyphilis patient prognosis.Keywords
This publication has 31 references indexed in Scilit:
- Regulatory T Cells in Peripheral Blood and Cerebrospinal Fluid of Syphilis Patients with and without Neurological InvolvementPLOS Neglected Tropical Diseases, 2013
- CXCL13 as a Cerebrospinal Fluid Marker for Neurosyphilis in HIV-Infected Patients With SyphilisSexually Transmitted Diseases, 2010
- Neuromyelitis optica (Devic's disease) in a patient with syphilisMultiple Sclerosis Journal, 2007
- Polyclonal B cell activation in infections: infectious agents’ devilry or defense mechanism of the host?Journal of Leukocyte Biology, 2007
- Symptomatic Relapse of Neurologic Syphilis after Benzathine Penicillin G Therapy for Primary or Secondary Syphilis in HIV-Infected PatientsClinical Infectious Diseases, 2006
- Biological Basis for SyphilisClinical Microbiology Reviews, 2006
- Predominant Autoantibody Production by Early Human B Cell PrecursorsScience, 2003
- Treatment of Syphilis 2001: Nonpregnant AdultsClinical Infectious Diseases, 2002
- From Infection to AutoimmunityJournal of Autoimmunity, 2001
- AUTOANTIBODIES ARE ANTI-IDIOTYPE ANTIBODIES TO ANTIVIRAL ANTIBODIESThe Lancet, 1983